Intranasal oxytocin for treating mother-infant attachment problems in postnatal depressio
Not Applicable
Completed
- Conditions
- Postnatal mental health / mother-infant attachmentPregnancy and ChildbirthPostnatal depression
- Registration Number
- ISRCTN92184014
- Lead Sponsor
- HS Greater Glasgow & Clyde (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
1. Mother with history of low mood (recorded Edinburgh Postnatal Depression Score of ten or greater) with baby aged 8-16 weeks
2. Mother aged 18 ? 50 years
Exclusion Criteria
1. Baby born before 38 weeks
2. Significant obstetric complications
3. Significant medical condition of mother or baby
4. Substantial neurological or visual impairment of mother or baby
5. Mother non-English speaking
6. Mother continuing to breast feed
7. Mother has physical condition which might affect nasal drug absorption (eg. URTI)
8. Mother responsible for care of another child at time of home visit
9. Mother pregnant
10. Mothers on antidepressant medication will not be excluded from the study; however we will record if a subject is on medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of mutual eye region gaze between mother and baby
- Secondary Outcome Measures
Name Time Method 1. CARE index will be calculated from the video footage (ie. at 45mins post-spray administration on both occasions)<br>2. Neonatal perception index will be completed at 0 and 45 minutes each time